Immunoassay quantification of human insulin added to ternary parenteral nutrition containers: comparison of two methods
- 234 Downloads
Adding insulin directly into infusion bags seems to be a useful method for controlling hyperglycemia in patients under ternary parenteral nutrition (TPN). Its efficacy is assessed by glycemic monitoring but few data are available on insulin stability in this situation. Among the various methods for quantifying insulin levels in human serum, the immunoassay ones seemed potentially appropriate for a TPN admixture containing high lipid concentrations. We sought to identify and validate which of two immunoassay methods was the better to quantify human insulin and consequently be adapted to studying its stability in a TPN admixture. Two immunoassay methods to quantify recombinant human insulin were assessed in industrial TPN: an immunoradiometric assay (IRMA) and an immunoelectrochemiluminometric assay (IECMA). Validation trials for both methods were based on the accuracy profile method. Interference with immunometric assays due to the high lipidic content of TPN was eliminated through an improved preparation protocol using a bovine serum albumin (BSA) diluted in phosphate buffer saline (PBS). The relative total error of IECMA varied from 1.74 to 4.52% while it varied from −0.32 to 8.37% with IRMA. Only IECMA provided an accuracy profile with a 95% confidence interval of calculated-tolerance limits falling between the chosen acceptance limits (i.e., total error ≤±10%). IECMA combined with a BSA dilution is a simple and semi-automatic method that provides an accurate quantification of human insulin in a TPN admixture without any interference from lipids.
KeywordsHuman insulin Parenteral nutrition solutions Immunoassay Validation Accuracy profile
The authors wish to thank Mrs. Alexandra Tavernier, M.A. University of Glasgow, U.K.; Professeur Agrégée, University of Lille, for her extensive revision of the final manuscript.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.McMahon MM, Nystrom E, Braunschweig C, Miles J, Compher C, American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors, et al. A.S.P.E.N. Clinical guidelines: nutrition support of adult patients with hyperglycemia. JPEN J Parenter Enteral Nutr. 2013;37:23–36.CrossRefGoogle Scholar
- 2.Edakkanambeth Varayil J, Yadav S, Miles JM, Okano A, Kelly DG, Hurt RT, et al. Hyperglycemia during home parenteral nutrition administration in patients without diabetes. JPEN J Parenter Enteral Nutr. 2015.Google Scholar
- 4.Mirtallo J, Canada T, Johnson D, Kumpf V, Petersen C, Sacks G, et al. Safe practices for parenteral nutrition. JPEN J Parenter Enteral Nutr. 2004;28:S39–70.Google Scholar
- 5.Bassons T, Maria Sanchez J, Bassas L, Cardona D, Ordonez J, Bonal J. Insulina recuperada según los componentes de la nutrición parenteral. Rev SENPE. 1985;4:93–9.Google Scholar
- 11.Hess C, Thomas A, Thevis M, Stratmann B, Quester W, Tschoepe D, et al. Simultaneous determination and validated quantification of human insulin and its synthetic analogues in human blood serum by immunoaffinity purification and liquid chromatography-mass spectrometry. Anal Bioanal Chem. 2012;404:1813–22.CrossRefGoogle Scholar
- 13.Martínez-Subiela S, Cerón JJ. Effects of hemolysis, lipemia, hyperbilirrubinemia, and anticoagulants in canine C-reactive protein, serum amyloid A, and ceruloplasmin assays. Can Vet J. 2005;46:625–9.Google Scholar
- 18.Sapin R, Le Galudec V, Gasser F, Pinget M, Grucker D. Elecsys insulin assay: free insulin determination and the absence of cross-reactivity with insulin lispro. Clin Chem. 2001;47:602–5.Google Scholar
- 21.Hubert P, Nguyen-Huu J-J, Boulanger B, Chapuzet E, Chiap P, Cohen N, et al. Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal—part II. J. Pharm. Biomed. Anal. 2007;45:70–81.Google Scholar
- 22.COFRAC. SH GTA 04 Guide technique d’accréditation de vérification (portée A)/validation (portée B) des méthodes en biologie médicale [Internet]. 2011 [cited 2017 Jan 10]. Available from: https://www.cofrac.fr/documentation/SH-GTA-04.